Anixa Biosciences files SEC 10-K Annual Report: Key Details
Anixa Biosciences Inc recently filed its SEC Form 10-K Annual Report for the period ending October 31, 2024. The company, specializing in pharmaceutical preparations, submitted a total of 64 documents as part of this filing, including key attachments such as the Form 10-K, EX-14, and EX-23.1. Investors and stakeholders can access the complete submission text file, as well as various XBRL files, to gain insight into the company’s financial performance and operations over the past year.
Attachments:
1. Form 10-K
2. EX-14
3. EX-23.1
Additional Information:
– Mailing Address: 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE CA 95118
– Business Address: 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE CA 95118
– Phone Number: 408-708-9808
– CIK: 0000715446
– IRS No.: 112622630
– State of Incorporation: DE
– Fiscal Year End: 10/31
– Form Type: 10-K
– Act: 34
– File No.: 001-37492
– Film No.: 25523959
– SIC: 2834 Pharmaceutical Preparations(CF Office: 03 Life Sciences)
For more detailed information and access to all the documents filed by Anixa Biosciences Inc, you can visit the SEC website.
